Showing results (201-210 of 321) with videos related to
Sort By:
Pageof 33
Human Brain Mapping|August 13, 2019
Cerebral lesion correlates of sympathetic cardiovascular activation in multiple sclerosisKlemens Winder, Ralf A Linker, Frank Seifert, et al.Neurological Research and Practice|September 27, 2021
Index event of cerebral amyloid angiopathy (CAA) determines long-term prognosis and recurrent events (retrospective analysis and clinical follow-up)Andrea Wagner, Christiane Groetsch, Sibylle Wilfling, et al.Journal of Neuroimmunology|April 6, 2020
Functional role of endogenous Kv1.4 in experimental demyelinationMaría Nazareth González-Alvarado, Caroline Rötger, Laura Berger, et al.The American Journal of Pathology|June 22, 2017
Testosterone Differentially Affects T Cells and Neurons in Murine and Human Models of Neuroinflammation and NeurodegenerationMegan G Massa, Christina David, Stefanie Jörg, et al.Blood|April 1, 1987
Improved results of treatment of adult acute lymphoblastic leukemiaC A Linker, L J Levitt, M O'Donnell, et al.Multiple Sclerosis and Related Disorders|January 14, 2020
Objective sensor-based gait measures reflect motor impairment in multiple sclerosis patients: Reliability and clinical validation of a wearable sensor deviceFelix Flachenecker, Heiko Gaßner, Julius Hannik, et al.Journal of Neurology|August 2, 2018
Lesion correlates of secondary paroxysmal dyskinesia in multiple sclerosisKilian Fröhlich, Klemens Winder, Ralf A Linker, et al.Journal of Neurology|November 1, 2018
Peripheral CD19<sup>+</sup> B-cell counts and infusion intervals as a surrogate for long-term B-cell depleting therapy in multiple sclerosis and neuromyelitis optica/neuromyelitis optica spectrum disordersGisa Ellrichmann, Jan Bolz, Maren Peschke, et al.Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology|May 24, 2014
Angiotensin IV is induced in experimental autoimmune encephalomyelitis but fails to influence the diseaseArndt Manzel, Oliver Domenig, Bjoern Ambrosius, et al.Annals of Clinical and Translational Neurology|June 22, 2018
The NRF2 pathway as potential biomarker for dimethyl fumarate treatment in multiple sclerosisAnna Hammer, Anne Waschbisch, Kristina Kuhbandner, et al.Pageof 33